Neurodevelopmental and neurodegenerative models of schizophrenia: White matter at the center stage

Schizophrenia Bulletin

Volumn 40, Issue 4, 2014, Pages 721-728

  Kochunov, Peter ^a   Hong, L Elliot ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

diffusion tensor imaging; etiology of schizophrenia; white matter integrity

Indexed keywords

AGE DISTRIBUTION; ARCUATE FASCICULUS; ARTICLE; BRAIN DEVELOPMENT; CELL DENSITY; COGNITION; CORPUS CALLOSUM; CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; FRONTAL LOBE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MOOD DISORDER; MYELINATION; NERVE DEGENERATION; NEUROBIOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL LOBE; UNCINATE FASCICULUS; WHITE MATTER; BIOLOGICAL MODEL; BRAIN; GROWTH, DEVELOPMENT AND AGING; NERVE TRACT; PATHOLOGY;

BRAIN; DIFFUSION TENSOR IMAGING; GRAY MATTER; HUMANS; LONGITUDINAL STUDIES; MODELS, BIOLOGICAL; NEURAL PATHWAYS; SCHIZOPHRENIA; WHITE MATTER;

EID: 84902574209     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu070     Document Type: Article

References (84)

1. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res. 1995;16:87-110.
2. Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci. 2002;25:409-432.
3. Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry. 2012;17:1228-1238.
4. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10:434-449.
5. Murray RM, O'Callaghan E, Castle DJ, Lewis S W. A neurode-velopmental approach to the classifcation of schizophrenia. Schizophr Bull. 1992;18:319-332.
6. Knoll JLt, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B. Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull. 1998;24:365-379.
7. Anderson JE, O'Donnell BF, McCarley RW, Shenton ME. Progressive changes in schizophrenia: do they exist and what do they mean? Restor Neurol Neurosci. 1998;12:175-184.
8. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci. 1995;3:89-97.
9. Repovs G, Csernansky JG, Barch DM. Brain network connectivity in individuals with schizophrenia and their siblings. Biol Psychiatry. 2011;69:967-973.
10. Weinberger DR. On the plausibility of "the neurodevelopmen-tal hypothesis" of schizophrenia. Neuropsychopharmacology. 1996;14(suppl 3):1S-11S.
11. Lillrank SM, Lipska BK, Weinberger DR. Neurodevelopmental animal models of schizophrenia. Clin Neurosci. 1995;3:98-104.
12. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 1982;17:319-334.
13. Pantelis C, Yücel M, Wood SJ, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull. 2005;31:672-696.
14. Sun D, Phillips L, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res. 2009;108:85-92.
15. Rapoport JL, Addington A, Frangou S. The neurodevelop-mental model of schizophrenia: what can very early onset cases tell us? Curr Psychiatry Rep. 2005;7:81-82.
16. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129-140.
17. Woods BT. Is schizophrenia a progressive neurodevelopmen-tal disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry. 1998;155:1661-1670.
18. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry. 1999;46:729-739.
19. Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in frst episode schizophrenia. Biol Psychiatry. 2001;49:487-499.
20. McCarley RW, Wible CG, Frumin M, et al. MRI anatomy of schizophrenia. Biol Psychiatry. 1999;45:1099-1119.
21. Pantelis C, Stuart G W, Nelson HE, Robbins TW, Barnes TR. Spatial working memory defcits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. Am J Psychiatry. 2001;158:1276-1285.
22. Rimol LM, Nesvåg R, Hagler DJ Jr, et al. Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry. 2012;71:552-560.
23. Andreasen NC. The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin Neurosci. 2010;12:409-415.
24. Jeste DV, Wolkowitz OM, Palmer B W. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull. 2011;37:451-455.
25. McGlashan TH. The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiatry. 1984;41:586-601.
26. McGlashan TH. The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample. Arch Gen Psychiatry. 1984;41:573-585.
27. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150:1115-1121.
28. Kirkpatrick B. Schizophrenia as a systemic disease. Schizophr Bull. 2009;35:381-382.
29. Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophr Bull. 2008;34:1024-1032.
30. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309-315.
31. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004;101:8174-8179.
32. Yakovlev PI, Lecours AR. Regional Development of the Brain in Early Life. Boston, MA: Blackwell Scientifc Publications; 1967.
33. Kochunov P, Williamson DE, Lancaster J, et al. Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiol Aging. 2012;33:9-20.
34. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 2002;15:435-455.
35. Mädler B, Drabycz SA, Kolind SH, Whittall KP, MacKay AL. Is diffusion anisotropy an accurate monitor of myelina-tion? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn Reson Imaging. 2008;26:874-888.
36. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 2003;20:1714-1722.
37. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage. 2005;26:132-140.
38. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97:11050-11055.
39. Lerch JP, Evans AC. Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage. 2005;24:163-173.
40. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 1997;387:167-178.
41. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging. 2009;30:507-514.
42. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309-315.
43. Cancelliere A, Mangano FT, Air EL, et al. DTI values in key white matter tracts from infancy through adolescence. AJNR Am J Neuroradiol. 2013;34:1443-1449.
44. Flechsig P. Developmental (myelogenetic) localisation of the cerebral cortex in the human. Lancet. 1901;158:1027-1030.
45. Kochunov P, Glahn DC, Lancaster J, et al. Blood pressure and cerebral white matter share common genetic factors in Mexican Americans. Hypertension. 2011;57:330-335.
46. Westlye LT, Walhovd KB, Dale AM, et al. Differentiating maturational and aging-related changes of the cerebral cortex by use of thickness and signal intensity. Neuroimage. 2010;52:172-185.
47. Kochunov P, Glahn DC, Lancaster J, et al. Fractional anisot-ropy of cerebral white matter and thickness of cortical gray matter across the lifespan. Neuroimage. 2011;58:41-49.
48. Kochunov P, Williamson DE, Lancaster J, et al. Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiol Aging. 2012;33:9-20.
49. Kochunov P, Glahn DC, Rowland LM, et al. Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression. Biol Psychiatry. 2013;73:482-491. doi:10.1016/j.biopsych.2012.10.002.
50. Wright S, Kochunov P, Chiappelli J, et al. Accelerated white matter aging in schizophrenia: role of white matter blood perfusion. Neurobiol Aging. 2014. doi:10.1016/j. neurobiolaging.2014.02.016.
51. Davis KL, Stewart DG, Friedman JI, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry. 2003;60:443-456.
52. Hof PR, Haroutunian V, Friedrich VL Jr, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry. 2003;53:1075-1085.
53. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67:269-275.
54. Mitkus SN, Hyde TM, Vakkalanka R, et al. Expression of oligodendrocyte-associated genes in dorsolateral prefron-tal cortex of patients with schizophrenia. Schizophr Res. 2008;98:129-138.
55. Uranova N, Orlovskaya D, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597-610.
56. Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res. 2002;27:1193-1200.
57. Vostrikov V, Uranova N. Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treatment. 2011;2011:174689.
58. Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fbers and oli-godendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment. 2011;2011:325789.
59. Woods BT, Yurgelun-Todd D, Goldstein JM, Seidman LJ, Tsuang MT. MRI brain abnormalities in chronic schizophrenia: one process or more? Biol Psychiatry. 1996;40:585-596.
60. Turetsky B, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry. 1995;52:1061-1070.
61. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 1992;49:921-926.
62. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60:585-594.
63. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 1999;56:367-374.
64. Horsfeld MA, Jones DK. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases-a review. NMR Biomed. 2002;15:570-577.
65. Mori T, Ohnishi T, Hashimoto R, et al. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res. 2007;154:133-145.
66. Friedman JI, Tang C, Carpenter D, et al. Diffusion tensor imaging fndings in frst-episode and chronic schizophrenia patients. Am J Psychiatry. 2008;165:1024-1032.
67. Glahn DC, Curran JE, Winkler AM, et al. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry. 2012;71:6-14.
68. Nazeri A, Chakravarty MM, Felsky D, et al. Alterations of superfcial white matter in schizophrenia and relationship to cognitive performance. Neuropsychopharmacology. 2013;38:1954-1962. doi:10.1038/npp.2013.93.
69. Alba-Ferrara LM, de Erausquin GA. What does anisotropy measure? Insights from increased and decreased anisotropy in selective fber tracts in schizophrenia. Front Integr Neurosci. 2013;7:9.
70. Perez-Iglesias R, Tordesillas-Gutierrez D, McGuire PK, et al. White matter integrity and cognitive impairment in frst-epi-sode psychosis. Am J Psychiatry. 2011;167:451-458.
71. Karlsgodt KH, Niendam TA, Bearden CE, Cannon TD. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry. 2009;66:562-569.
72. Carletti F, Woolley JB, Bhattacharyya S, et al. Alterations in white matter evident before the onset of psychosis. Schizophr Bull. 2012;38:1170-1179.
73. Bloemen OJ, de Koning MB, Schmitz N, et al. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med. 2010;40:1297-1304.
74. Szeszko PR, Ardekani BA, Ashtari M, et al. White matter abnormalities in frst-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry. 2005;162:602-605.
75. Perez-Iglesias R, Tordesillas-Gutierrez D, Barker GJ, et al. White matter defects in frst episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage. 2013;49:199-204.
76. Peters BD, Blaas J, de Haan L. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned? J Psychiatr Res. 2013;44:993-1004.
77. Nazeri A, Chakravarty MM, Felsky D, et al. Alterations of superfcial white matter in schizophrenia and relationship to cognitive performance. Neuropsychopharmacology. 2013;38:1954-1962.
78. Kubicki M, McCarley R, Westin CF, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41:15-30.
79. Hubl D, Koenig T, Strik W, et al. Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry. 2004;61:658-668.
80. Jones DK, Catani M, Pierpaoli C, et al. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp. 2006;27:230-238.
81. Kochunov P, Chiappelli J, Wright S, et al. Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia. Psychiatry Res Neuroimag. In press.
82. Kubicki M, Styner M, Bouix S, et al. Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum. Schizophr Res. 2008;106:125-131.
83. Reis Marques T, Taylor H, Chaddock C, et al. White matter integrity as a predictor of response to treatment in frst episode psychosis. Brain. 2014;137:172-182.
84. Hadley JA, Nenert R, Kraguljac NV, et al. Ventral tegmental area/midbrain functional connectivity and response to antipsy-chotic medication in schizophrenia. Neuropsychopharmacology. 2014;39:1020-1030.